News
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
BioMark Expands its Liquid Biopsy Platform with two Groundbreaking Publications in Breast Cancer Detection BioMark
Form 7 Monthly Progress Report November 2024 Name of Listed Issuer: Trading Symbol: Number of
Form 7 Monthly Progress Report October 2024 Name of Listed Issuer: Trading Symbol: Number of
BioMark Diagnostics and Principal Investigators Publish an Important Approach Using Metabolomics and ML to Identify
BioMark Diagnostics Completes Testing of Over 5,400 subjects as Part of a Validation Study for
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2